Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory inflation

Executive Summary

Former maximum fine of $1,000 per count for misdemeanor violations under FD&C Act has been increased to $100,000 for misdemeanor by corporation or individual not resulting in death, $250,000 for misdemeanor by individual resulting in death, and $500,000 for misdemenaor by a corporation resulting in death. The changes are required by the Criminal Fine Enforcement Act of 1984. "The Pink Sheet" incorrectly reported an increase to a $5,000 maximum (Nov. 11, In Brief).

Former maximum fine of $1,000 per count for misdemeanor violations under FD&C Act has been increased to $100,000 for misdemeanor by corporation or individual not resulting in death, $250,000 for misdemeanor by individual resulting in death, and $500,000 for misdemenaor by a corporation resulting in death. The changes are required by the Criminal Fine Enforcement Act of 1984. "The Pink Sheet" incorrectly reported an increase to a $5,000 maximum (Nov. 11, In Brief).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS009276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel